SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054536
Filing Date
2021-11-04
Accepted
2021-11-04 16:48:39
Documents
53
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q onct-10q_20210930.htm   iXBRL 10-Q 1678374
2 EX-10.1 onct-ex101_100.htm EX-10.1 28557
3 EX-31.1 onct-ex311_7.htm EX-31.1 21863
4 EX-31.2 onct-ex312_12.htm EX-31.2 21790
5 EX-32.1 onct-ex321_6.htm EX-32.1 7801
6 EX-32.2 onct-ex322_8.htm EX-32.2 7853
  Complete submission text file 0001564590-21-054536.txt   5670041

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA onct-20210930.xsd EX-101.SCH 49516
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE onct-20210930_cal.xml EX-101.CAL 26538
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE onct-20210930_def.xml EX-101.DEF 113924
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20210930_lab.xml EX-101.LAB 339410
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20210930_pre.xml EX-101.PRE 234520
12 EXTRACTED XBRL INSTANCE DOCUMENT onct-10q_20210930_htm.xml XML 893267
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 211380696
SIC: 2834 Pharmaceutical Preparations